O028 Combination Pharmacological Therapy Targeting Multiple Mechanisms of Sleep Apnea

INTRODUCTION: Currently two leading experimental pharmacological interventions are under investigation for obstructive sleep apnea (OSA). Acetazolamide, which acts to stabilise ventilatory control, lowers the apnea-hypopnea index (AHI) by ∼38%. More recently, atomoxetine-plus-oxybutynin (“AtoOxy”),...

Descripción completa

Detalles Bibliográficos
Autores principales: Sands, S, Hess, L, Bertisch, S, Collet, J, Gell, L, Calianese, N, Vena, D, Azarbarzin, A, Taranto-Montemurro, L, Wellman, A, Landry, S, Thomson, L, Joosten, S, Hamilton, G, Edwards, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
ORAL PRESENTATIONS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109095/
http://dx.doi.org/10.1093/sleepadvances/zpac029.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109095/
http://dx.doi.org/10.1093/sleepadvances/zpac029.027

Ejemplares similares